Sds Optic (WAR:SDS) Other Stockholders Equity: zł-0.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:SDS Sds Optic SA WAR:SDS
22 GF Score
Price zł3.50
! 4 Warning Signs
View Full Analysis

What is Sds Optic Other Stockholders Equity?

Sds Optic WAR:SDS -2.23% 22 Other Stockholders Equity is zł-0.00 Mil as of Mar. 2026. GuruFocus rates WAR:SDS with a GF Score™ of 22/100. The stock has 4 warning signs investors should review.

Sds Optic's Other Stockholders Equity for the quarter that ended in Mar. 2026 was zł-0.00 Mil.

Sds Optic's quarterly Other Stockholders Equity declined from Sep. 2025 (zł-0.00 Mil) to Dec. 2025 (zł-0.01 Mil) but then increased from Dec. 2025 (zł-0.01 Mil) to Mar. 2026 (zł-0.00 Mil).

Sds Optic's annual Other Stockholders Equity increased from Dec. 2023 (zł-0.00 Mil) to Dec. 2024 (zł0.00 Mil) but then declined from Dec. 2024 (zł0.00 Mil) to Dec. 2025 (zł-0.01 Mil).

Sds Optic Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Sds Optic's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sds Optic Other Stockholders Equity Chart

Sds Optic Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial 0.00 0.00 -0.00 0.00 -0.01

Sds Optic Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -0.00 -0.01 -0.00
WAR:SDS
22GF Score
Sds Optic SA WAR:SDS
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sds Optic Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of zł-0.00 Mil mean?
Sds Optic (WAR:SDS) has a Other Stockholders Equity of zł-0.00 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Sds Optic and its competitors.
Is Sds Optic's Other Stockholders Equity too high?
Sds Optic's current Other Stockholders Equity is zł-0.00 Mil. Overall, Sds Optic has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Sds Optic's Other Stockholders Equity compare to ABT and SYK?
Sds Optic's Other Stockholders Equity of zł-0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Devices & Instruments company?
A good Other Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Sds Optic and its competitors. Sds Optic's current Other Stockholders Equity is zł-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sds Optic stock overvalued right now?
Sds Optic (WAR:SDS) has a current Other Stockholders Equity of zł-0.00 Mil. The current Other Stockholders Equity is zł-0.00 Mil. Sds Optic's overall GF Score™ is 22/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Sds Optic (WAR:SDS), the current Other Stockholders Equity is zł-0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sds Optic Business Description

Address ul. Gleboka 39, Centrum Ecotech-Complex, Block A, Lublin, POL, 20-612
Sds Optic SA is engaged in developing and creating solutions on the borderline of biochemistry, engineering and fiber optic technologies, used in cancer diagnosis and treatment. The company has designed an Opto-biological methodology that allows for instant cellular processes studies including in-vivo cancer diagnosis with single-cell resolution. The company is also focused on manufacturing Optoelectronics.
22GF Score

Get the complete analysis for WAR:SDS

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł3.50
Price